The global Capecitabine Market is entering a high-growth phase as oncology treatments shift from intravenous infusions to convenient, oral home-care regimens. Capecitabine—a fluoropyrimidine carbamate—is a prodrug that converts into the active cancer-fighting agent 5-FU within the tumor. In 2025, this medication remains a cornerstone for treating gastrointestinal and breast cancers, p... https://in.linkedin.com/company/data-bridge-market-research